JPRN-UMIN000006087
Completed
未知
Evaluation of the efficacy and the safety of processed onion product on human muscle metabolism for the inpatient. - Clinical trial of intake of processed onion product for the inpatient.
ConditionsInpatient
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Inpatient
- Sponsor
- The University of Tokushima
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Primary muscle disease 2\)Chronic kidney disease 3\)Diabetic nephropathy(Stage3\) 4\)Subject who uses any medication of the muscle. 5\)Subject who causes ill health by the intake of the onion and the welsh onion . 6\)Subject who takes the health food supplement including many vegetable extracts. 7\)Pregnant female, lactating female 8\)Subject who can't undergo MRI scan. 9\)Subject who has been enrolled in this study within the last 2weeks. 10\)The case that subject refuses to participate in this study. 11\)The case that it is difficult to participate in this study in the opinion of the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of the Efficacy and Safety of the Use of Perfectha Deep Lidocaine in the Treatment of Nasolabial Folds, Marionette Lines and Temple HollowingR23.4Changes in skin textureDRKS00029739Sinclair Pharmaceuticals LtdEden HouseLakeside70
Active, not recruiting
Phase 1
se of an antidiabetic drug (Empagliflozin) to lower the blood level of 1,5-anhydroglucitol in patients deficient in the glucose-6-phosphate transporter (GSD1b) and the phosphatase G6PC3, both of the endoplasmic reticulum, to treat their recurrent infections by normalizing their blood neutrophil counts. Neutrophils are the most abundant white blood cells in our blood that are essential to help fighting infections. 1,5-anhydroglucitol is a sugar derivative with no known function.(1) Severe Congenital Neutropenia type 4 (SNC4) due to a deficiency in G6PC3, a phosphatase of the endoplasmic also known a Ubiquitous glucose-6-phosphatase and (2) the neutropenia in Glycogen Storage Disease type 1b due to a deficiency in the glucose-6-phosphate transporter (G6PT / SLC37A4) of the endoplasmic reticulum.Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2018-004191-35-BECliniques universitaires Saint-Luc5
Recruiting
Phase 3
A clinical study to evaluate the efficacy and safety of the Vamana karma followed with two Rasayanas Takradhara and Rasaoushadi in treatment of psoriasis.Health Condition 1: null- Psoriasis (Kitibha)CTRI/2016/02/006631Central council for Research in Ayurvedic sciences CCRAS110
Completed
Not Applicable
The evaluation of the efficacy and the safety of rikkunshito on anorexia in Parkinson's disease patientsJPRN-UMIN000009626Saitama Medical Center,Saitama Medical University20
Recruiting
Not Applicable
The evaluation of the efficacy and the safety of rikkunshito on anorexia in elderly dementia patientsElderly dementia patientsJPRN-UMIN000011198Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine20